Title : Genetic polymorphisms of metabolic enzymes and the pharmacokinetics of indapamide in Taiwanese subjects.

Pub. Date : 2014 Mar

PMID : 24357089






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The PG/PK study of indapamide demonstrated that the polymorphic SNPs CYP2C9 rs4918758 and CYP2C19 rs4244285 appeared to confer lowered enzyme activity, as indicated by increased C max (25% ~ 64%), increased area under the plasma level-time curves (30~76%), increased area under the time infinity (43% ~ 80%), and lower apparent clearance values than PK for wild-type indapamide. Indapamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 The PG/PK study of indapamide demonstrated that the polymorphic SNPs CYP2C9 rs4918758 and CYP2C19 rs4244285 appeared to confer lowered enzyme activity, as indicated by increased C max (25% ~ 64%), increased area under the plasma level-time curves (30~76%), increased area under the time infinity (43% ~ 80%), and lower apparent clearance values than PK for wild-type indapamide. Indapamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 Our results reinforce the biochemical support of CYP2C19 in indapamide metabolism and identify a possible new participating enzyme CYP2C9. Indapamide cytochrome P450 family 2 subfamily C member 9 Homo sapiens